Playback speed
10 seconds
Updated Results From the Momentum Phase 3 Study of Momelotinib vs. Danazol in Symptomatic and Anemic MF Pts Previously Treated With a JAK Inhibitor
By
ASH 2022 Conference Coverage
FEATURING
Aaron Gerds
By
ASH 2022 Conference Coverage
FEATURING
Aaron Gerds
218 views
December 16, 2022
Login to view comments.
Click here to Login